PA
INN

PharVision Advisers’s Summit Hotel Properties INN Stock Holding History

PharVision Advisers’s Portfolio INN Stock Details INN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
+16,336
New +$90.2K 2.16% 10
2025
Q4 		– Sell
-39,995
Closed -$220K – 839
2025
Q3 		$220K Buy
+39,995
New +$218K 0.12% 430

Other funds holding INN

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
H2CM
H/2 Credit Manager Stamford, Connecticut $526M AUM 70.67% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PharVision Advisers's INN Position: Q2 2026 in Review

PharVision Advisers opened a new position in Summit Hotel Properties (INN) in Q2 2026: 16,336 shares worth $115K. The stake represents 2.16% of the portfolio and ranks #10 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in INN as recently as Q3 2025.

PharVision Advisers first reported a position in INN in Q3 2025 and has held it in 2 quarters since. The position peaked at $220K in Q3 2025. 203 funds tracked by Wall St. Rank hold INN as of Q2 2026.

  • PharVision Advisers held 16,336 shares of Summit Hotel Properties worth $115K as of Q2 2026.
  • Summit Hotel Properties was a new PharVision Advisers position in Q2 2026.
  • Summit Hotel Properties made up 2.16% of PharVision Advisers's portfolio in Q2 2026, its #10 holding.
  • PharVision Advisers first reported a position in Summit Hotel Properties in Q3 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Summit Hotel Properties position peaked at $220K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Summit Hotel Properties as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.